Panoramic Ventures — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
Cloverly provides Catalyst, a commercial operating system for carbon credit project developers to manage inventory, pricing, sales, and delivery and to reach sales channels and buyers from one system.
CleantechClimate TechSaaSAtlanta, US
Jason Rubottom(Executive Officer, Director)inJames Heath(Director)
BoardAnthony Oni(Director)Vasant Kamath(Director)inMike Dowdle(Director)in
Co-investorsBackwards CapitalCircadian VenturesCreativeCoKnoll VenturesMission One CapitalNew Climate Ventures+6 more
CyDeploy provides a platform that uses automated asset discovery, digital twins, and AI-driven testing to help organizations understand the impact of technology changes like patches and digital transformations on their environment.
AI & Machine LearningCloud ComputingCybersecurityDeveloper ToolsEnterprise SoftwareLaurel, US
Tina Williams-Koroma(Founder & CEO)David Steadman(Technical Co-Founder/President of Engineering)
Co-investorsBIP VenturesMaryland TEDCOTechstarsTEDCOPreface Ventures
Traction-stage healthcare company led by Sara Well.
Los Angeles, US
Sara Well(Executive Officer, Director)inBrandon Edwards(Director)
BoardPaul Iaffaldano(Director)in
Co-investorsBIP Ventures
Karoo provides value-based care solutions for cardiology networks, health systems, and health plans, combining on-site and virtual care teams with proprietary technology to improve patient outcomes and reduce costs.
HealthtechSaaS
Ian Koons(Founder)in
Co-investorsAloft VCBIP VenturesDria VenturesFirstMile VenturesFirst Trust Capital PartnersInflect Health
ShiftMed operates an on-demand healthcare staffing platform that connects hospitals, health systems, and long-term care facilities with credentialed nurses (CNAs, LPNs, RNs) to fill shifts and manage their workforce.
Digital HealthFuture of WorkHealthtechMarketplaces
Todd Walrath(Founder)in
Co-investorsBIP VenturesMotley Fool VenturesBlue Heron Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.